1. Reva Medical files for bankruptcy
Reva Medical, a San Diego-based devicemaker that specializes in vascular devices, has filed for Chapter 11 bankruptcy, Mass Device reported.
2. Insys bankruptcy plan gets court OK
Insys Therapeutics, the first drugmaker to go bankrupt after opioid litigation, won court approval for its bankruptcy plan Jan. 16.
3. Florida drugmaker files for bankruptcy after recall
KRS Global Biotechnology, a Boca Raton, Fla.-based drug compounding facility, filed for Chapter 11 bankruptcy after “unforeseen business circumstances,” the Sun Sentinel reported Jan. 16.
4. New Jersey drugmaker files for bankruptcy
Melinta Therapeutics, an antibiotics maker based in Morristown, N.J., filed for Chapter 11 bankruptcy Dec. 27.
5. California biotech files for bankruptcy
Sienna Biopharmaceuticals, a Westlake Village, Calif.-based biopharmaceutical company, has filed for bankruptcy.
More articles on pharmacy:
Drug shortages update: 5 things to know
Grocery store pharmacies across the country finding it harder to stay in business
AbbVie to donate $1M of drug China says will combat coronavirus
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.